Ticker Details
GoodRx Holdings, Inc.
IPO Date:	September 23, 2020
Sector:	Healthcare
Industry:	Health Information Services
Market Cap:	$805.05M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.42 | 2.73%
Avg Daily Range (30 D):	$0.05 | 2.17%
Avg Daily Range (90 D):	$0.06 | 2.74%

Institutional Daily Volume
Avg Daily Volume:	1.95M
Avg Daily Volume (30 D):	1.62M
Avg Daily Volume (90 D):	2.42M

Trade Size
Avg Trade Size (Sh.):	125
Avg Trade Size (Sh.) (30 D):	153
Avg Trade Size (Sh.) (90 D):	194

Institutional Trades
Total Institutional Trades:	2,661
Avg Institutional Trade:	$1.83M
Avg Institutional Trade (30 D):	$1.11M
Avg Institutional Trade (90 D):	$1.14M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$2.23M
Avg Closing Trade (30 D):	$1.2M
Avg Closing Trade (90 D):	$1.21M
Avg Closing Volume:	127.48K

News

Apr 15, 2026 @ 5:25 PM GoodRx Rallies As Wegovy HD Rollout Targets Self-P... Source: Vandana Singh

Feb 6, 2026 @ 1:15 AM Amazon Is Now Offering Novo Nordisk's Wegovy Pill ... Source: Reuben Gregg Brewer

Jan 5, 2026 @ 5:23 PM Novo Nordisk's Wegovy Weight Loss Pill Hits US Pha... Source: Vandana Singh

Nov 17, 2025 @ 6:01 PM Novo Nordisk Leans Into Affordability Amid Rising ... Source: Vandana Singh

Sep 18, 2025 @ 2:00 PM Telepharmacy Market Size to Reach US$ 21.89 Billio... Source: S&S Insider Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.09	$.02	$.09
Diluted EPS	$.09	$.02	$.09
Revenue	$796.85M	$194.79M	$796.85M
Gross Profit
Net Income / Loss	$30.44M	$5.43M	$30.44M
Operating Income / Loss	$87.49M	$22.68M	$87.49M
Cost of Revenue
Net Cash Flow	$-186.53M	$-11.71M	$-186.53M
PE Ratio	25.22